Team:Rice University/STRATEGY
From 2008.igem.org
(Difference between revisions)
m (→Pathway Design for Resveratrol Biosynthesis) |
(→Circuit Design for Recombination in Yeast) |
||
Line 31: | Line 31: | ||
=== Circuit Design for Recombination in Yeast=== | === Circuit Design for Recombination in Yeast=== | ||
- | [[Image:circuit.png| | + | [[Image:circuit.png|center|700px|thumb|[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122020 BBa_K122020].]] |
*Our design goal was to construct a circuit that would propagate through several generations without a selection pressure and be highly expressed during all stages of fermentation. To address these goals we constructed three expression cassettes that, when concatenated, would integrate genomically into a highly transcribed locus, have an inducible selectable marker, and express the resveratrol pathway highly under anaerobic conditions. | *Our design goal was to construct a circuit that would propagate through several generations without a selection pressure and be highly expressed during all stages of fermentation. To address these goals we constructed three expression cassettes that, when concatenated, would integrate genomically into a highly transcribed locus, have an inducible selectable marker, and express the resveratrol pathway highly under anaerobic conditions. | ||
<BR><BR><BR> | <BR><BR><BR> | ||
- | {|align=" | + | {|align="center" style="border-color:#FF0000; text-indent: 10pt;text-align:left" border="10" cellpadding="20" width="50%" |
| | | | ||
*[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122012 Cassette 1] - anaerobically induced expression of 4CL:STS | *[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122012 Cassette 1] - anaerobically induced expression of 4CL:STS | ||
Line 42: | Line 42: | ||
*#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122003 tCYC1] - bi-directional transcriptional stop. | *#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122003 tCYC1] - bi-directional transcriptional stop. | ||
|} | |} | ||
- | + | <BR><BR> | |
- | {|align=" | + | {|align="center" style="border-color:#33CC33; text-indent: 10pt;text-align:left" border="10" cellpadding="20" width="50%" |
| | | | ||
*[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122015 Cassette 2] - inducible expression of Bleocin resistance. | *[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122015 Cassette 2] - inducible expression of Bleocin resistance. | ||
Line 49: | Line 49: | ||
*#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122004 tADH1] - bi-directional transcriptional stop. Strategically placed downstream of Zeor and upstream of pADH1 to prevent erroneous recombination at those regions. | *#[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122004 tADH1] - bi-directional transcriptional stop. Strategically placed downstream of Zeor and upstream of pADH1 to prevent erroneous recombination at those regions. | ||
|} | |} | ||
- | + | <BR><BR> | |
- | {|align=" | + | {|align="center" style="border-color:#3333CC; text-indent: 10pt;text-align:left" border="10" cellpadding="20" width="50%" |
| | | | ||
*[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122021 Cassette 3] - constitutive expression of TAL | *[http://partsregistry.org/wiki/index.php?title=Part:BBa_K122021 Cassette 3] - constitutive expression of TAL |
Revision as of 01:01, 30 October 2008
OUR TEAM ::: SUMMARY ::: INTRODUCTION ::: STRATEGY ::: RESULTS ::: ONGOING WORK
OUR TEAM ::: SUMMARY ::: INTRODUCTION ::: STRATEGY ::: RESULTS ::: ONGOING WORK |